Your browser doesn't support javascript.
loading
Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management.
Rahman, Syed Nazrin Ruhina; Pawde, Datta Maroti; Katari, Oly; Hmingthansanga, Victor; Shunmugaperumal, Tamilvanan.
Afiliação
  • Rahman SNR; National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, C/O NETES Institute of Technology & Science, NH-37, Santipur, Parli Part, Mirza, Guwahati, Assam, 781125, India.
  • Pawde DM; National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, C/O NETES Institute of Technology & Science, NH-37, Santipur, Parli Part, Mirza, Guwahati, Assam, 781125, India.
  • Katari O; National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, C/O NETES Institute of Technology & Science, NH-37, Santipur, Parli Part, Mirza, Guwahati, Assam, 781125, India.
  • Hmingthansanga V; National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, C/O NETES Institute of Technology & Science, NH-37, Santipur, Parli Part, Mirza, Guwahati, Assam, 781125, India.
  • Shunmugaperumal T; National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, C/O NETES Institute of Technology & Science, NH-37, Santipur, Parli Part, Mirza, Guwahati, Assam, 781125, India. tamilvanan1@yahoo.co.in.
AAPS PharmSciTech ; 21(2): 36, 2019 Dec 26.
Article em En | MEDLINE | ID: mdl-31879832

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes do Olho Seco / Ciclosporina / Inibidores de Calcineurina / Liberação Controlada de Fármacos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes do Olho Seco / Ciclosporina / Inibidores de Calcineurina / Liberação Controlada de Fármacos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article